Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Leiomyosarcoma × cediranib × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Fallopian Tube Neoplasms 4 Ovarian Neoplasms 3 Triple Negative Breast Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Uterine Cervical Neoplasms 1 Solitary Fibrous Tumor, Pleural 1 Small Cell Lung Carcinoma 1 Prostatic Neoplasms 1 Neoplasm Metastasis 1 Mesothelioma, Malignant 1 Melanoma 1 Leiomyosarcoma 1 Glioblastoma 1 Fallopian Tube Mucinous Adenocarcinoma 1 Colorectal Neoplasms 1 Carcinosarcoma 1 Carcinoma, Endometrioid 1

Interventions

Radiotherapy 3 Radiation 3 pazopanib 2 Nivolumab 2 Doxorubicin 2 talimogene laherparepvec 1 sotigalimab 1 rucaparib 1 ribociclib 1 olaparib 1 futibatinib 1 durvalumab 1 cediranib 1 cabozantinib 1 Temozolomide 1 Specimen Handling 1 Magnetic Resonance Spectroscopy 1 Ifosfamide 1 Gemcitabine 1 Everolimus 1 Erlotinib Hydrochloride 1 Biopsy 1 BO-112 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03851614 2026-02-09

DAPPER

University Health Network, Toronto

Phase 2 Active not recruiting

Leiomyosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡